No definition available.

Number of core value drivers in corporate strategy.

No definition available.

The number of unique proprietary platform technologies to discover, design and develop medicines and diagnostics to target misfolded proteins.

No definition available.

Accrued expenses

No definition available.

The disclosure of detailed information about trade payables and accrued liabilities.

No definition available.

Accrued interest income.

No definition available.

The expected rate of interest rates on retirement savings capital is used as a significant actuarial assumption to determine the present value of a defined benefit obligation.

No definition available.

Additional grant awarded

No definition available.

Adjustments for depreciation expense for right-of-use assets to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for gain (loss) on lease modifications to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for increase (decrease) in accrued expenses to reconcile profit (loss) to net cash flow from (used in) operating activities.

No definition available.

Adjustments for increase (decrease) in current contract liabilities

No definition available.

Adjustments for increase (decrease) in non-current contract liabilities

No definition available.

Capital authorized to be issued under shelf registration statement

No definition available.

The cash outflow or inflow for deposit of rent.

No definition available.

The number of installments for satisfying a milestone payment associated with a collaborative agreement.

No definition available.

Payment(s) received for milestone payments associated with a collaborative agreement.

No definition available.

Period of time that notice is required to be given for cancellation of the collaborative agreement contract, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

Collaborative agreement, potential receivables for option exercise fee and potential development, commercial and sales-based milestones

No definition available.

The total potential value of the collaborative agreement.

No definition available.

Collaborative agreement, upfront payments received

No definition available.

The decrease in number of treasury shares through equity incentive plans.

No definition available.

Defined benefit plans, percentage of contributions by employees

No definition available.

Defined benefit plans, percentage of contributions by employer

No definition available.

The description of the entity's accounting policy for judgments that management has made in the process of applying the entity's accounting policies that have the most significant effect on amounts recognized in the financial statements along with information about the assumptions that the entity makes about the future, and other major sources of estimation uncertainty at the end of the reporting period, that have a significant risk of resulting in a material adjustment to the carrying amounts of assets and liabilities within the next year.

No definition available.

The description of the entity's accounting policy for the basis for how the entity classifies assets and liabilities as current and non-current.

No definition available.

The description of the entity's material accounting policy information for restructuring expense.

No definition available.

Disclosure of amounts recognised in balance sheet from defined benefit plans

No definition available.

Disclosure of amounts recognised in statement of other comprehensive income from defined benefit plans

No definition available.

Disclosure of amounts recognised in statement of profit and loss from defined benefit plans

No definition available.

The disclosure of cash and cash equivalents and short-term deposits not classified as cash equivalents.

No definition available.

The disclosure of detailed information about carrying amounts of financial assets and financial liabilities.

No definition available.

The disclosure of detailed information about the expiration of income tax losses that may be carried forward.

No definition available.

The disclosure of detailed information about income tax reconciliation.

No definition available.

Disclosure of detailed information about prepaid expenses and accrued income including contract assets

No definition available.

Disclosure of prepaid expenses and accrued income including contract assets

No definition available.

The disclosure of right-of-use assets impact on the company's statements of income/(loss) and statements of cash flows.

No definition available.

The disclosure of trade and other payables and accrued expenses

No definition available.

Employee benefits expense excluding share-based compensation

No definition available.

The amount of deposits held in escrow.

No definition available.

The estimated lease term, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.

No definition available.

Expense from acceleration of share-based payments relating to restructuring activities.

No definition available.

The expense for leases recognized through profit and loss.

No definition available.

The description of the entity's accounting policy for fair value of financial assets and liabilities.

No definition available.

Follow-on grant funding received

No definition available.

Follow-on grant funding received, total for joint arrangement

No definition available.

The description of the entity's accounting policy for grant income.

No definition available.

The period or time limit over which financial losses of the entity for preceding years can be deducted from the taxable revenue for a period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

Increase (decrease) in finance income compared to prior period.

No definition available.

Increase (decrease) in finance income (expense) compared to prior period

No definition available.

Increase (decrease) in net defined benefit liability (asset) resulting from benefits deposited

No definition available.

Increase (decrease) in profit (loss) resulting from reasonably possible increase or decrease in interest rates

No definition available.

Increase (decrease) in profit (loss) resulting from reasonably possible strengthening or weakening of reporting currency against other relevant currencies

No definition available.

Increase (decrease) in tax losses available for offset against future taxable profits

No definition available.

The increase in the number of ordinary shares issued under incentive plans.

No definition available.

The increase in equity resulting from the issue of shares under incentive plans.

No definition available.

The increase in equity through the issue of restricted share awards.

No definition available.

The maximum term of options granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

The maximum term of other equity instruments (i.e., other than share options) granted for a type of share-based payment arrangement that existed at any time during the period, in 'PnYnMnDTnHnMnS' format; for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.

No definition available.

Miscellaneous other current receivables

No definition available.

Net proceeds from issuance of shares

No definition available.

The number of deposits in escrow accounts.

No definition available.

Number of development milestones that may occur prior to option exercise included in transaction price

No definition available.

Number of equity-based instrument plans approved by the entity.

No definition available.

The number of financial institutions holding the entity's deposits of cash and cash equivalents and short-term financial assets.

No definition available.

The number of grants received.

No definition available.

The number of other equity instruments (i.e., other than share options) exercised in a share-based payment arrangement.

No definition available.

The number of performance obligations identified applicable to the entity's assessment of a specific contractual arrangement.

No definition available.

The number of persons that are the included in Board of Directors excluding the Chief Executive Officer.

No definition available.

The number of persons that comprise key management of the entity that are Executive Management.

No definition available.

The number of representatives in a joint steering committee by each party as per the agreement.

No definition available.

Number of shares issued during the period

No definition available.

Number of shares issued in public offerings during the period.

No definition available.

Number of shares issued that have not yet been registered in commercial register.

No definition available.

The number of treasury shares sold during the period

No definition available.

Operating expense excluding employee benefits expense and depreciation.

No definition available.

Number of operating segments reported by the entity.

No definition available.

Payments for share issue costs and stamp duty associated with public offerings, classified as financing activities

No definition available.

Payments for share issue costs associated with sale of treasury shares in public offerings, classified as financing activities

No definition available.

Payments (proceeds) from purchases (sales) of short-term financial assets, classified as investing activities

No definition available.

Percentage of reasonably possible increase or decrease in interest rates

No definition available.

Percentage of reasonably possible strengthening or weakening of reporting currency against other relevant currencies

No definition available.

Potential increase is equity through conversion of debt instruments

No definition available.

The potential increase in equity from share-based payment transactions.

No definition available.

Potential number of shares issued from conversion of debt instruments

No definition available.

The total number of potential shares issued through share-based payment transactions.

No definition available.

The amount of cash inflow from issuance of public offerings of common shares net of underwriting fees.

No definition available.

Proceeds from issuance of shares through equity plans, net of transaction costs

No definition available.

Proceeds from sale of treasury shares in public offerings, net of underwriting fees and transaction costs

No definition available.

Amount of property plant and equipment acquired through noncash investing activities.

No definition available.

Number of reportable segments reported by the entity.

No definition available.

The increase (decrease) in equity from sale or issue of public offerings net of underwriting fees and transaction costs.

No definition available.

The increase (decrease) in equity from sale or issue of treasury shares net of underwriting fees and transaction costs

No definition available.

The number of treasury shares issued or sold.

No definition available.

Schedule of cash and cash equivalents by currency

No definition available.

Tabular disclosure of information related to the contractual undiscounted cash flows.

No definition available.

The disclosure of detailed information about the estimated lease term by right-of-use asset by category.

No definition available.

The disclosure of detailed information about the useful life of property, plant and equipment.

No definition available.

Schedule of short-term deposits not classified as cash equivalents

No definition available.